Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR

CRISPR

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The roles of the acetyltransferase domains of the chromatin regulators KAT6A and KAT6B in vivo.

Development (Cambridge, England)·2026

Same author

The benchmarking and application of tag-degraders in vivo to validate therapeutic targets.

Nature communications·2026

Same author

Redox regulation of EGFR activation by thioredoxin reductase 3 drives resistance to EGFR inhibitors in triple-negative breast cancer.

Cell death discovery·2026

Same author

Cas9-expressing HC-04 hepatocytes facilitate CRISPR-based analysis of Plasmodium falciparum sporozoite-host interactions.

PLoS genetics·2026

Same author

The kinase domain of RIPK3 tunes its scaffolding functions.

Cell death and differentiation·2026

Same author

Author Correction: A1 is induced by pathogen ligands to limit myeloid cell death and NLRP3 inflammasome activation.

EMBO reports·2025

Same journal

Tracking Synthetic Adhesins on Bacterial Surfaces with Immunofluorescence Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

High-Performance Computing in Tandem Mass Spectrometry (MS/MS) Peptide Identification.

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

Engineering and Adapting Disulfide-Containing Proteins to Enable Intracellular Functionality.

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

AI-Driven Protein Research: From Prediction to Design.

Methods in molecular biology (Clifton, N.J.)·2026

Same journal

Methods for the In Vitro Selection of Protein and Peptide Libraries Using mRNA Display.

Methods in molecular biology (Clifton, N.J.)·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 22, 2026

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Published on: January 5, 2018

Using CRISPR/Cas9 Technology for Manipulating Cell Death Regulators.

Andrew J Kueh^1,2, Marco J Herold^3,4

¹Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052, Australia.

Methods in Molecular Biology (Clifton, N.J.)

|April 25, 2016

Summary

This summary is machine-generated.

This study introduces an inducible lentiviral vector for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene editing. This method improves targeting efficiency and reduces lethality in essential genes.

Keywords:

CRISPR/Cas9 Guide RNA Inducible Lentiviral

More Related Videos

A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization

A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization

Published on: September 2, 2021

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Published on: February 28, 2025

Related Experiment Videos

Last Updated: Mar 22, 2026

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Published on: January 5, 2018

A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization

A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization

Published on: September 2, 2021

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Published on: February 28, 2025

Area of Science:

Molecular Biology
Gene Editing Technologies
Biotechnology

Background:

CRISPR/Cas9 is a powerful gene editing tool for creating targeted mutations.
Constitutive CRISPR/Cas9 expression can lead to low efficiency and lethality from essential gene mutations.

Purpose of the Study:

To develop an inducible CRISPR/Cas9 system for enhanced gene editing.
To overcome limitations of constitutive CRISPR/Cas9 expression.

Main Methods:

Utilized a lentiviral vector platform for inducible CRISPR/Cas9 delivery.
Employed cell transduction and enrichment strategies.
Induced CRISPR/Cas9 expression for targeted mutations.

Main Results:

Achieved rapid transduction and enrichment of CRISPR/Cas9 positive cells.
Demonstrated high levels of targeted mutations upon induction.
Showcased improved efficiency compared to constitutive expression.

Conclusions:

An inducible lentiviral vector platform enhances CRISPR/Cas9 gene editing efficiency.
This inducible system mitigates issues of low targeting efficiency and lethality.
Offers a more controlled and effective approach for CRISPR/Cas9 applications.